Ballentine Partners’s Dr. Reddy's Laboratories RDY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.18M | Buy |
145,218
+70,110
| +93% | +$1.05M | 0.03% | 179 |
|
|
2025
Q1 | $991K | Sell |
75,108
-29,607
| -28% | -$391K | 0.02% | 295 |
|
|
2024
Q4 | $1.65M | Buy |
104,715
+27,455
| +36% | +$434K | 0.03% | 208 |
|
|
2024
Q3 | $1.23M | Buy |
77,260
+11,195
| +17% | +$178K | 0.02% | 245 |
|
|
2024
Q2 | $1.01M | Sell |
66,065
-890
| -1% | -$13.6K | 0.02% | 261 |
|
|
2024
Q1 | $982K | Buy |
66,955
+13,330
| +25% | +$196K | 0.02% | 256 |
|
|
2023
Q4 | $746K | Buy |
53,625
+19,500
| +57% | +$271K | 0.02% | 280 |
|
|
2023
Q3 | $456K | Buy |
34,125
+1,875
| +6% | +$25.1K | 0.01% | 339 |
|
|
2023
Q2 | $407K | Buy |
+32,250
| New | +$407K | 0.01% | 366 |
|